Are Pharma & IT Funds Back In The Green?

Will IT Perform?

While the period following the pandemic turned challenging for the pharmaceutical and information technology sectors, events in recent times have shaped out to be tailwinds for both these sectors and the mutual funds that invest in such sectoral themes. The following article highlights the reasons why these sectors may be back in favour among investors while also taking note of the red flags that need to be taken into account

In the wake of the waning of the pandemic and the global markets regaining their footing, the shine seemed to have dimmed on the IT and pharmaceutical funds, leaving many investors disheartened. But in the world of finance, where resilience often trumps adversity, a new chapter has begun to unfold. Since the onset of June 2023, these sectors, that were hugely underperforming, have staged a remarkable comeback, leaving astute investors wondering whether it’s time to revisit their investment strategies and set sail toward the horizon of renewed potential.